(Reuters) — Belgian proton therapy specialist Ion Beam Applications (EBR:IBAB) lost a third of its $1 billion market value today after it cut its guidance for 2018 and 2019, blaming project delays and increased competition. The company is a leading maker of machines that deliver cancer-fighting proton beams, a super-precise form of radiation, but it has […]
